Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia

[1]  J. Wagner,et al.  Alternative donor hematopoietic cell transplantation for Fanconi anemia. , 2015, Blood.

[2]  F. Corbella,et al.  HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  H. Deeg,et al.  Cyclophosphamide-Based In Vivo T-Cell Depletion for HLA-Haploidentical Transplantation in Fanconi Anemia , 2012, Pediatric hematology and oncology.

[4]  P. Rosenberg,et al.  How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel , 2011, American journal of medical genetics. Part A.

[5]  Allen R. Chen,et al.  High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. , 2010, Blood.

[6]  Richard J. Jones,et al.  Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases , 2008, Bone Marrow Transplantation.

[7]  Allen R. Chen,et al.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  R. Storb,et al.  HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  J. Wagner,et al.  Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. , 2007, Blood.

[10]  H. Deeg,et al.  Low‐dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA‐matched related donors in patients with Fanconi anaemia , 2005, British journal of haematology.

[11]  S. Heimfeld,et al.  HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. , 2003, Blood.

[12]  M. Leffell,et al.  Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  J. Radich,et al.  Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. , 2001, Blood.

[14]  R. Berger,et al.  In Vitro Effect of Cyclophosphamide Metabolites on Chromosomes of Fanconi Anaemia Patients , 1980, British journal of haematology.

[15]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.